|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6 BGN | -0.66% |
|
-0.99% | +4.90% |
| Feb. 29 | Sopharma AD Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | Sopharma AD Reports Sales Results for the Month and Eleven Months Ended November 2023 | CI |
Sopharma AD reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was BGN 1,218.8 million compared to BGN 1,179.33 million a year ago. Net income was BGN 67.88 million compared to BGN 50.53 million a year ago.
Basic earnings per share from continuing operations was BGN 0.56 compared to BGN 0.4 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +4.90% | 545M | |
| -30.56% | 11.21B | |
| -29.95% | 6.23B | |
| +7.42% | 6B | |
| -10.27% | 5.89B | |
| -0.73% | 4.72B | |
| +53.60% | 4.32B | |
| -9.42% | 3.77B | |
| -13.25% | 3.4B | |
| -6.06% | 3.03B |
SOPHARMA AD 
